Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruben Alvarez

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Journal of Thoracic Disease|December 10, 2017
Extracorporeal membrane oxygenation system as a bridge to reparative surgery in ventricular septal defect complicating acute inferoposterior myocardial infarctionJose Rozado, Isaac Pascual, Pablo Avanzas, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
3-Amido-3-aryl-piperidines: A Novel Class of Potent, Selective, and Orally Active GlyT1 InhibitorsEmmanuel Pinard, Daniela Alberati, Ruben Alvarez-Sanchez, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2009
Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of type-2 diabetesEric Kitas, Peter Mohr, Bernd Kuhn, et al.
Molecular Metabolism|February 5, 2016
Incretin-like effects of small molecule trace amine-associated receptor 1 agonistsSusanne Raab, Haiyan Wang, Sabine Uhles, et al.
The Plant Journal : for Cell and Molecular Biology|June 23, 2021
Time-series transcriptomics reveals a BBX32-directed control of acclimation to high light in mature Arabidopsis leavesRuben Alvarez-Fernandez, Christopher A Penfold, Gregorio Galvez-Valdivieso, et al.
Journal of Medicinal Chemistry|August 17, 2012
Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblastsYimin Qian, Matthew Hamilton, Achyutharao Sidduri, et al.
Human Immunology|January 9, 2007
Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw*07 on acute rejectionMaria R Moya-Quiles, Ruben Alvarez, Manuel Miras, et al.
Cancer Cell|July 18, 2020
IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer MetastasisRasmus Siersbæk, Valentina Scabia, Sankari Nagarajan, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Journal of Thoracic Disease|December 10, 2017
Extracorporeal membrane oxygenation system as a bridge to reparative surgery in ventricular septal defect complicating acute inferoposterior myocardial infarctionJose Rozado, Isaac Pascual, Pablo Avanzas, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
3-Amido-3-aryl-piperidines: A Novel Class of Potent, Selective, and Orally Active GlyT1 InhibitorsEmmanuel Pinard, Daniela Alberati, Ruben Alvarez-Sanchez, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2009
Sulfonylureido thiazoles as fructose-1,6-bisphosphatase inhibitors for the treatment of type-2 diabetesEric Kitas, Peter Mohr, Bernd Kuhn, et al.
Molecular Metabolism|February 5, 2016
Incretin-like effects of small molecule trace amine-associated receptor 1 agonistsSusanne Raab, Haiyan Wang, Sabine Uhles, et al.
The Plant Journal : for Cell and Molecular Biology|June 23, 2021
Time-series transcriptomics reveals a BBX32-directed control of acclimation to high light in mature Arabidopsis leavesRuben Alvarez-Fernandez, Christopher A Penfold, Gregorio Galvez-Valdivieso, et al.
Journal of Medicinal Chemistry|August 17, 2012
Discovery of highly selective and orally active lysophosphatidic acid receptor-1 antagonists with potent activity on human lung fibroblastsYimin Qian, Matthew Hamilton, Achyutharao Sidduri, et al.
Human Immunology|January 9, 2007
Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw*07 on acute rejectionMaria R Moya-Quiles, Ruben Alvarez, Manuel Miras, et al.
Cancer Cell|July 18, 2020
IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer MetastasisRasmus Siersbæk, Valentina Scabia, Sankari Nagarajan, et al.
Pageof 3